Center-within-trial versus trial-level evaluation of surrogate endpoints (Q1623614): Difference between revisions

From MaRDI portal
Created claim: Wikidata QID (P12): Q30370596, #quickstatements; #temporary_batch_1714635560004
Created claim: DBLP publication ID (P1635): journals/csda/RenfroSXLSS14, #quickstatements; #temporary_batch_1731543907597
 
(One intermediate revision by one other user not shown)
Property / cites work
 
Property / cites work: Choice of units of analysis and modeling strategies in multilevel hierarchical models / rank
 
Normal rank
Property / cites work
 
Property / cites work: Surrogate Marker Evaluation from an Information Theory Perspective / rank
 
Normal rank
Property / cites work
 
Property / cites work: Validation of Surrogate Markers in Multiple Randomized Clinical Trials with Repeated Measurements / rank
 
Normal rank
Property / cites work
 
Property / cites work: Validation of Surrogate Markers in Multiple Randomized Clinical Trials with Repeated Measurements: Canonical Correlation Approach / rank
 
Normal rank
Property / cites work
 
Property / cites work: Prentice's Approach and the Meta-Analytic Paradigm: A Reflection on the Role of Statistics in the Evaluation of Surrogate Endpoints / rank
 
Normal rank
Property / cites work
 
Property / cites work: Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points / rank
 
Normal rank
Property / cites work
 
Property / cites work: The validation of surrogate endpoints in meta-analyses of randomized experiments / rank
 
Normal rank
Property / cites work
 
Property / cites work: The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: A perspective on surrogate endpoints in controlled clinical trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Validation of Surrogate Endpoints in Multiple Randomized Clinical Trials with Discrete Outcomes / rank
 
Normal rank
Property / cites work
 
Property / cites work: Validation of a longitudinally measured surrogate marker for a time-to-event endpoint / rank
 
Normal rank
Property / cites work
 
Property / cites work: Comparative assessment of trial-level surrogacy measures for candidate time-to-event surrogate endpoints in clinical trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Simplified hierarchical linear models for the evaluation of surrogate endpoints / rank
 
Normal rank
Property / cites work
 
Property / cites work: Flexible surrogate marker evaluation from several randomized clinical trials with continuous endpoints, using R and SAS / rank
 
Normal rank
Property / DBLP publication ID
 
Property / DBLP publication ID: journals/csda/RenfroSXLSS14 / rank
 
Normal rank

Latest revision as of 01:34, 14 November 2024

scientific article
Language Label Description Also known as
English
Center-within-trial versus trial-level evaluation of surrogate endpoints
scientific article

    Statements

    Center-within-trial versus trial-level evaluation of surrogate endpoints (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    23 November 2018
    0 references
    clinical trials
    0 references
    meta-analysis
    0 references
    surrogate endpoints
    0 references
    survival analysis
    0 references

    Identifiers